Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Amortizatization of Intangibles (2011 - 2012)

Angiodynamics posted quarterly Amortizatization of Intangibles of $206000.0 for Q2 2012, down 19.53% on a QoQ basis from $256000.0 in Q1 2012.

Angiodynamics (ANGO) has 2 years of Amortizatization of Intangibles data on file, last reported at $206000.0 in Q2 2012.

  • For the quarter ending Q2 2012, Amortizatization of Intangibles changed N/A year-over-year to $206000.0; the trailing twelve-month figure through May 2012 stood at $707000.0 (changed N/A YoY), and the FY2012 full-year result was $707000.0, changed N/A from the prior year.
  • Amortizatization of Intangibles for Q2 2012 stood at $206000.0, down from $256000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $256000.0 in Q1 2012 and bottomed at $16000.0 in Q3 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 10.20 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 10.05 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 600,000.00
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn -
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 10.06 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 11.42 Mn
10 Angiodynamics 497.07 Mn 459.26 Mn 41.48 Mn -

Historic Data

Download Data 🔒
DateValue
May 31, 2012 206,000.00
May 31, 2012 206,000.00
Feb 29, 2012 256,000.00
Feb 29, 2012 256,000.00
Nov 30, 2011 229,000.00
Nov 30, 2011 229,000.00
Aug 31, 2011 16,000.00
Aug 31, 2011 16,000.00